1 |
Koran Academy of Family Medicine. 1995. Disease prevention and health promotion in Korea: Hepatitis B, pp. 134-140, Korea Medical Publishing Co., Seoul
|
2 |
Leontiou, A.P., M.M. Coogan, and S. Aspinall. 1999. Disinfection of dental diamond burs contaminated with hepatitis B virus. J. Prosthet. Dent. 82, 332-335
|
3 |
Samaranayake, P. 2002. Re-emergence of tuberculosis and its variants: implications for dentistry. Int. Dent. J. 52, 330-336
|
4 |
Shim, J.K., D.W. Kim, T.H. Chung, J.K. Kim, J.I. Suh, C. Park, Y.C. Lee, T.W. Chung, E.Y. Song, and C.H. Kim. 2001. Characterization of a cell line HFH-T2, producing viral particles, from primary human fetal hepatocytes infected with hepatitis B Virus. J. Microbiol. Biotechnol. 11, 186-192
|
5 |
Bradley, D.W. 1999. Hepatitis viruses: Their role in human cancer. Proc. Assoc. Am. Physicians 111, 588-93
|
6 |
Hollinger, F.B. 1996. Comprehensive control (or elimination) of hepatitis B virus transmission in the United States. Gut 38(Suppl 2), S24-S30
|
7 |
Rosen, H.R. 2000. Retransplantation for hepatitis C: implications of different policies. Liver Transpl. 6(Suppl. 2), S41-S46
|
8 |
Mitra, A.K. 1999. Hepatitis C-related hepatocellular carcinoma: Prevalence around the world, factors interacting, and role of genotypes. Epidemiol. Rev. 21, 180-187
|
9 |
Bae, C.S., G.Y. Lim, J.S. Kim, and B.K. Hur. 2002. Quadrivalent combined vaccine, including diphtheria toxoid, tetanus toxoid, detoxified whole cell pertussis, and hepatitis B surface antigen. J. Microbiol. Biotechnol. 12, 338-343
|
10 |
Beltrami, E.M., I.T. Williams, C.N. Shapiro, and M.E. Chamberland. 2000. Risk and management of blood-borne infections in health care workers. Clin. Microbiol. Rev. 13, 385-407
|
11 |
Song, K.B., K.S. Choi, W.P. Lang, and J.J. Jacobson. 1999. Hepatitis B prevalence and infection control among dental health care workers in a community in South Korea. J. Public. Health. Dent. 59, 39-43
|
12 |
Eguchi, J., K. Ishihara, A. Watanabe, Y. Fukumoto, and K. Okuda. 2003. PCR method is essential for detecting Mycobacterium tuberculosis in oral cavity samples. Oral Microbiol. Immunol. 18, 156-159
|
13 |
Pierre, C., D. Lecossier, Y. Boussougant, D. Bocart, V. Joly, P. Yeni, and A.J. Hance. 1991. Use of a reamplification protocol improves sensitivity of detection of Mycobacterium tuberculosis in clinical samples by amplification of DNA. J. Clin. Microbiol. 29, 712-717
|
14 |
Juszczyk, J. 2000. Clinical course and consequences of hepatitis B infection. Vaccine 18(Suppl. 1), S23-S25
|
15 |
Kim, B.J., S.H. Lee, M.A. Lyu, S.J. Kim, G.H. Bai, G.T. Chae, E.C. Kim, C.Y. Cha, and Y.H. Kook. 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37, 1714-1720
|
16 |
Shin, H.R. and J.B. Kim. 1994. Positivity of HBV markers and changes of HBV markers after vaccination among healthy workers. Korean J. Epidemiol. 16, 163-171
|
17 |
World Health Organization. 1997. Hepatitis C. Wrld. Hlth. Org. Wkly. Epidemiol. Rec. 72, 65-69
|
18 |
Araujo, M.W. and S. Andreana. 2002. Risk and prevention of transmission of infectious diseases in dentistry. Quintessence Int. 33, 376-382
|